Today, gold appears to have the edge over equities across both near-term and long-term horizons. But this comparison is coming when gold is scaling fresh peaks, even as equities have lost steam, observes Niranjan Avasthi, SVP, Edelweiss Asset Management.

The price that investors are paying for anticipated earnings from the Magnificent Seven companies hit the lowest level since September this week as the broader S&P 500 dropped 10% from its recent peak.

​​The outlook is bullish because the Nifty is not reacting adversely to the fall in the US markets and an unsystematic risk arising after a disclosure from a private bank in India.

Marcellus Investment Managers’ PMS AUM fell 64% to Rs 4,734 crore. Founder Saurabh Mukherjea welcomed criticism, citing past failures as learning experiences. The fund’s consistent compounders portfolio delivered a 17.4% CAGR, aligning with EPS growth. Marcellus acknowledged valuation missteps but expects a recovery.

Valuation guru Aswath Damodaran warns India faces more global resistance in its growth journey than China did. Rising trade uncertainties, driven by US tariffs, threaten market stability. Global indices, including Nasdaq, have reacted sharply, while Indian investor sentiment weakens amid FII outflows.

An SME IPO saw over 400x subscriptions last year but later plunged 50%, raising concerns over sustainability. Sebi introduced stricter norms, capping OFS at 20% and mandating profitability criteria. IPO proceeds can t repay promoter loans, reducing misuse. SME IPO subscriptions have since dropped sharply, curbing grey market activity.

Midcap stocks saw heavy selling, with the BSE Midcap index dropping over 2%, sharper than the Sensex’s 0.7% fall. Out of 132 index stocks, 104 ended negative.

The US Fed interest rate decision, global trends, tariff-related developments and trading activity of foreign investors will drive the equity market movement this week, analysts said. Among macroeconomic data announcement, WPI inflation for February is scheduled to be announced on Monday.

The combined market capitalisation of five of the top-10 most valued firms declined by Rs 93,357.52 crore, with IT giants Infosys and Tata Consultancy Services taking the biggest hit, in line with a weak trend in domestic equities.

Drug maker Allchem Lifescience has filed preliminary papers with markets regulator Sebi seeking its approval to raise funds through an initial public offering (IPO). The Gujarat-based company s proposed IPO comprises fresh issue of equity shares aggregating up to Rs 190 crore and an offer for sale (OFS) of 71.55 lakh equity shares by promoters, according to the draft red herring prospectus (DRHP).